CODAGENIX INC

From the company

Codagenix is combining live-attenuated virus design with codon deoptimization technology for a synthetic biology-based platform aimed at infectious disease. It designs hundreds of precise, stable edits into a viral genome to deliver vaccine solutions with the broad immunity benefits of live-attenuated viruses combined with safety, speed and scalability. The company is headquartered in Farmingdale, NY, and considers preclinical and clinical stage collaboration opportunities.